CNS Pharmaceuticals Completes Executive Leadership Team with Lynne Kelley as Chief Medical Officer

CNS Pharmaceuticals appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, completing its executive leadership team. Dr. Kelley brings 20 years of experience in drug development and regulatory strategy in oncology, rare diseases, and CNS. The newly formed team is committed to executing the company's evolution focused on patient and stakeholder value. Dr. Kelley has a proven track record of leading clinical programs and supporting regulatory approvals globally.